GlassScriptPhysician profile
Jennifer Frey
NPI 1619173176
$566.54
in general payments reported to CMS, 2019-2025
13 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $63.97 · 2022: $81.46 · 2023: $199 · 2024: $35.87 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $421.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $125.38 | 2025 | |
| Lilly USA, LLC | $103.60 | 2023 | |
| Novartis Pharmaceuticals Corporation | $67.52 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $63.80 | 2023 | |
| Boston Scientific Corporation | $43.12 | 2021-2023 | Lux-Dx Insertable Cardiac Monitor |
| E.R. Squibb & Sons, L.L.C. | $34.01 | 2022-2023 | |
| Kestra Medical Technology Services, INC. | $24.52 | 2025 | Assure Wcd |
| Abbott Laboratories | $21.80 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.82 | 2025 | Lifevest |
| Siemens Medical Solutions USA, INC. | $19.50 | 2024 | Acuson Origin Diagnostic Ultrasound System |
| Chiesi USA, INC. | $16.89 | 2025 | Cleviprex, Kengreal |
| Pfizer INC. | $16.37 | 2024 | |
| Genentech USA, INC. | $10.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Frey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.